Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 6:44 pm Purchase | 2026-04-27 | 13D | CLIMB BIO, INC. CLYM | RA Capital Management, L.P. | 22,631,401 33.000% | 4,628,144 (+25.71%) | Filing History |
| 2026-04-28 5:16 pm Purchase | 2026-04-21 | 13G | PRELUDE THERAPEUTICS INC PRLD | RA Capital Management, L.P. | 6,477,309 9.900% | 6,477,309 (New Position) | Filing History |
| 2026-04-27 4:46 pm Purchase | 2026-04-20 | 13G | JATT II ACQUISITION CORP USD O JATT | RA Capital Management, L.P. | 500,000 6.400% | 500,000 (New Position) | Filing History |
| 2026-04-23 4:29 pm Purchase | 2026-04-22 | 13D | ACRIVON THERAPEUTICS INC ACRV | RA Capital Management, L.P. | 12,284,906 28.800% | 3,888,888 (+46.32%) | Filing History |
| 2026-04-21 7:05 pm Purchase | 2026-04-20 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,896,519 19.900% | 157,495 (+1.24%) | Filing History |
| 2026-04-17 4:57 pm Unchanged | 2026-04-15 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 34,225,506 17.100% | 0 (Unchanged) | Filing History |
| 2026-04-15 5:31 pm Purchase | 2026-04-14 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,739,024 19.900% | 184,382 (+1.47%) | Filing History |
| 2026-04-13 5:22 pm Purchase | 2026-02-17 | 13G | ADICET BIO INC ACET | RA Capital Management, L.P. | 1,182,624 12.300% | 222,387 (+23.16%) | Filing History |
| 2026-04-10 6:25 pm Purchase | 2026-04-09 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,554,642 19.900% | 154,936 (+1.25%) | Filing History |
| 2026-04-08 6:45 pm Purchase | 2026-04-06 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,399,706 19.900% | 212,182 (+1.74%) | Filing History |
| 2026-04-07 5:59 pm Purchase | 2026-03-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA Capital Management, L.P. | 7,626,705 6.300% | 7,626,705 (New Position) | Filing History |
| 2026-04-07 4:13 pm Purchase | 2026-03-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | RA Capital Management, L.P. | 4,038,715 9.900% | 4,038,715 (New Position) | Filing History |
| 2026-04-06 6:54 pm Purchase | 2026-03-30 | 13G | ZAI LAB LTD ZLAB | RA Capital Management, L.P. | 57,435,330 5.200% | 57,435,330 (New Position) | Filing History |
| 2026-04-02 4:47 pm Purchase | 2026-03-26 | 13G | KARYOPHARM THERAPEUTICS INC CO KPTI | RA Capital Management, L.P. | 2,078,913 9.900% | 2,078,913 (New Position) | Filing History |
| 2026-04-01 5:09 pm Purchase | 2026-03-30 | 13D | VOR BIOPHARMA INC VOR | RA Capital Management, L.P. | 12,187,524 19.900% | 3,164,456 (+35.07%) | Filing History |
| 2026-03-30 8:38 pm Purchase | 2026-03-23 | 13G | XENCOR INC XNCR | RA Capital Management, L.P. | 4,736,739 6.500% | 4,736,739 (New Position) | Filing History |
| 2026-03-30 8:32 pm Purchase | 2026-03-26 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 34,225,506 17.500% | 8,772,496 (+34.47%) | Filing History |
| 2026-03-23 4:28 pm Purchase | 2026-03-19 | 13D | ACRIVON THERAPEUTICS INC ACRV | RA Capital Management, L.P. | 8,396,018 21.600% | 36,916 (+0.44%) | Filing History |
| 2026-03-23 4:25 pm Purchase | 2026-03-19 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 7,311,225 9.900% | 2,144,801 (+41.51%) | Filing History |
| 2026-03-20 4:13 pm Purchase | 2026-03-13 | 13G | EQUILLIUM INC EQ | RA Capital Management, L.P. | 6,480,209 9.900% | 6,480,209 (New Position) | Filing History |